Skip to main content
logo
NeoGenomics, Inc. (NEO)
NASDAQ: NEO · Real-Time Price · USD
5.16
+0.32 (6.61%)
At close: Aug 1, 2025, 4:00 PM
5.06
-0.10 (-1.94%)
After-hours: Aug 1, 2025, 7:31 PM EDT

Accolade Revenue

NeoGenomics had revenue of $181.33M in the quarter ending June 30, 2025, with 10.23% growth. This brings the company's revenue in the last twelve months to $689.19M, up 9.70% year-over-year. In the year 2024, NeoGenomics had annual revenue of $660.57M with 11.65% growth.

Revenue (ttm)
$689.19M
Revenue Growth
+9.70%
P/S Ratio
0.95
Revenue / Employee
$313,268
Employees
2,200
Market Cap
666.56M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024660.57M68.92M11.65%
Dec 31, 2023591.64M81.92M16.07%
Dec 31, 2022509.73M25.40M5.24%
Dec 31, 2021484.33M39.88M8.97%
Dec 31, 2020444.45M35.62M8.71%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
UnitedHealth Group422.82B
Johnson & Johnson90.63B
Merck & Co.63.62B
AbbVie57.37B
AstraZeneca56.50B
Novartis AG55.19B
Eli Lilly and Company49.00B
Novo Nordisk43.92B
Revenue Rankings

NEO News

More News